Ouvrages publiés à titre de seul auteur (1)
  1. 1. Wauthoz, N. (2014). La chimiothérapie inhalée pour combattre les tumeurs pulmonaires: Développement de poudres sèches pour inhalation à base de témozolomide.
    2.   Ouvrages publiés en collaboration (2)
  2. 1. Rosiere, R., Amighi, K., & Wauthoz, N. (2019). Nanotechnology-based targeted drug delivery systems for lung cancer: Nanomedicine-based inhalation treatments for lung cancer.
  3. 2. Wauthoz, N., & Amighi, K. (2015). Pulmonary drug delivery : Advances and Challenges: Formulation strategies for pulmonary drug delivery of poorly soluble drugs. Wiley.
    4.   Parties d'ouvrages collectifs (1)
  4. 1. Wauthoz, N., & Amighi, K. (2015). Formulation strategies for pulmonary delivery of poorly soluble drugs. In Pulmonary Drug Delivery: Advances and Challenges (pp. 87-121). wiley. doi:10.1002/9781118799536.ch5
    5.   Articles dans des revues avec comité de lecture (51)
  5. 1. Frangville, P., Tanwar, A. S., Kumar, S., Gelbcke, M., Wauthoz, N., Basov, S., Van Bael, M. J., Van Hecke, K., & Meyer, F. (2024). Sensing diversity in halogen-bonded multi-stimuli responsive materials: Light, pH, magnetism, and electron-rich species. Materials Today Chemistry, 40, 102234. doi:10.1016/j.mtchem.2024.102234
  6. 2. Xiroudaki, S., Sabbatini, S., Pecoraro, C., Cascioferro, S., Diana, P., Wauthoz, N., Antognelli, C., Monari, C., Giovagnoli, S., & Schoubben, A. (2023). Development of a new indole derivative dry powder for inhalation for the treatment of biofilm-associated lung infections. International journal of pharmaceutics, 631, 122492.
  7. 3. Davenne, T., Percier, P., Larbanoix, L., Moser, M., Leo, O., Meylan, E., Goriely, S., Gérard, P., Wauthoz, N., Laurent, S., Amighi, K., & Rosiere, R. (2022). Inhaled dry powder cisplatin increases antitumour response to anti-PD1 in a murine lung cancer model. Journal of controlled release, 353, 317-326. doi:10.1016/j.jconrel.2022.11.055
  8. 4. Ravon, F., Menchi, E., Lambot, C., Al Kattar, S., Chraibi, S., Remmelink, M., Fontaine, V., & Wauthoz, N. (2022). In vitro and in vivo local tolerability of a synergistic anti‐tuberculosis drug combination intended for pulmonary delivery. Journal of applied toxicology, 1-14. doi:10.1002/jat.4381
  9. 5. Menchi, E., El Khattabi, C., Pochet, S., Denis, O., Amighi, K., & Wauthoz, N. (2022). Optimization of Long-Acting Bronchodilator Dose Ratios Using Isolated Guinea Pig Tracheal Rings for Synergistic Combination Therapy in Asthma and COPD. Pharmaceuticals, 15(8). doi:https://doi.org/10.3390/ ph15080963
  10. 6. Gevenois, P., De Pauw, P., Schoonooghe, S., Delporte, C., Sebti, T., Amighi, K., Muyldermans, S., & Wauthoz, N. (2021). Development of Neutralizing Multimeric Nanobody Constructs Directed against IL-13: From Immunization to Lead Optimization. Journal of immunology (Baltimore, Md. : 1950), 207(10), 2608-2620. doi:10.4049/jimmunol.2100250
  11. 7. Chraibi, S., Rosiere, R., De Prez, E., Gérard, P., Antoine, M.-H., Langer, I., Nortier, J., Remmelink, M., Amighi, K., & Wauthoz, N. (2021). Preclinical tolerance evaluation of the addition of a cisplatin-based dry powder for inhalation to the conventional carboplatin-paclitaxel doublet for treatment of non-small cell lung cancer. Biomedicine & pharmacotherapy, 139, 111716. doi:10.1016/j.biopha.2021.111716
  12. 8. Chraibi, S., Rosiere, R., Larbanoix, L., Gérard, P., Hennia, I., Laurent, S., Vermeersch, M., Amighi, K., & Wauthoz, N. (2021). The combination of an innovative dry powder for inhalation and a standard cisplatin-based chemotherapy in view of therapeutic intensification against lung tumours. European journal of pharmaceutics and biopharmaceutics, 164, 93-104. doi:10.1016/j.ejpb.2021.04.018
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 Suivant >>